SKI Market

Indian Indices

Nifty

25,453.40 -88.40
(-0.35%)

Sensex

83,409.69 -287.60
( -0.34%)

Bank Nifty

56,999.20 -460.25
( -0.80%)

Nifty IT

38,879.10 45.95
( 0.12%)

Global Indices

Nasdaq

44,512.09 396.31
(0.90%)

Dow Jones

6,218.43 -7.52
(-0.12%)

Hang Seng

39,758.37 -227.96
(-0.57%)

Nikkei 225

8,785.33 24.37
(0.28%)

Forex

USD-INR

85.62 0.21
(0.25%)

EUR-INR

100.54 0.47
(0.47%)

GBP-INR

117.42 0.25
(0.22%)

JPY-INR

0.59 0.00
(0.57%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Ajanta Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

532331

INE031B01049

290.2218799

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

AJANTPHARM

34.55

31297.98

EPS(TTM)

Face Value()

Div & Yield %

72.53

1.12

Back

Kenvi Jewels standalone net profit declines 48.21% in the December 2024 quarter

Feb 10,2025

Net profit of Kenvi Jewels declined 48.21% to Rs 0.29 crore in the quarter ended December 2024 as against Rs 0.56 crore during the previous quarter ended December 2023. Sales declined 47.52% to Rs 46.89 crore in the quarter ended December 2024 as against Rs 89.34 crore during the previous quarter ended December 2023.

Particulars	Quarter Ended
	Dec. 2024	Dec. 2023	% Var.
Sales	46.89	89.34	-48
OPM %	1.13	1.10	-
PBDT	0.34	0.71	-52
PBT	0.34	0.71	-52
NP	0.29	0.56	-48

25,453.40 -88.40 (-0.35%)

83,409.69 -287.60 ( -0.34%)

56,999.20 -460.25 ( -0.80%)

38,879.10 45.95 ( 0.12%)

44,512.09 396.31 (0.90%)

6,218.43 -7.52 (-0.12%)

39,758.37 -227.96 (-0.57%)

8,785.33 24.37 (0.28%)

85.62 0.21 (0.25%)

100.54 0.47 (0.47%)

117.42 0.25 (0.22%)

0.59 0.00 (0.57%)